Skip to main content

and
  1. No Access

    Article

    A DNA methylation signature for the prediction of tumour recurrence in stage II colorectal cancer

    A major challenge in stage II colorectal carcinoma is to identify patients with increased risk of recurrence. Biomarkers that distinguish patients with poor prognosis from patients without recurrence are curre...

    Min Li, Congcong Zhu, Ying Xue, Changhong Miao, Rui** He in British Journal of Cancer (2023)

  2. Article

    Open Access

    EasyCatch, a convenient, sensitive and specific CRISPR detection system for cancer gene mutations

    Yin Liu, Yanling Chen, Lu Dang, Yixin Liu, Shisheng Huang, Sanyun Wu in Molecular Cancer (2021)

  3. Article

    Open Access

    Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma

    An amendment to this paper has been published and can be accessed via the original article.

    Jiajie Hou, He Zhang, Jun Liu, Zhenjun Zhao, Jianye Wang, Zhike Lu in Molecular Cancer (2020)

  4. Article

    Open Access

    YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma

    Dynamic N6-methyladenosine (m6A) modification was previously identified as a ubiquitous post-transcriptional regulation that affected mRNA homeostasis. However, the m6A-related epitranscriptomic alterations and f...

    Jiajie Hou, He Zhang, Jun Liu, Zhenjun Zhao, Jianye Wang, Zhike Lu in Molecular Cancer (2019)

  5. Article

    Open Access

    FATS is a transcriptional target of p53 and associated with antitumor activity

    Frequent mutations of p53 in human cancers exemplify its crucial role as a tumor suppressor transcription factor, and p21, a transcriptional target of p53, plays a central role in surveillance of cell-cycle ch...

    **feng Zhang, Qian Zhang, Jun Zhang, Li Qiu, Shuang-shuang Yan in Molecular Cancer (2010)